-
1Academic Journal
المؤلفون: the CAPTURE investigators
المساهمون: Interne Geneeskunde Vasculaire, Circulatory Health, MS Interne Geneeskunde
مصطلحات موضوعية: Cardiovascular Diseases/epidemiology, Cross-Sectional Studies, Diabetes Mellitus, Type 2/complications, Glucagon-Like Peptide 1/therapeutic use, Glucagon-Like Peptide-1 Receptor/agonists, Glucose/therapeutic use, Heart Disease Risk Factors, Humans, Hypoglycemic Agents/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, cardiovascular disease, GLP-1, SGLT2 inhibitor, type 2 diabetes, antidiabetic drug, Internal Medicine, Endocrinology, Diabetes and Metabolism, Journal Article, Research Support, Non-U.S. Gov't
وصف الملف: application/pdf
-
2Academic Journal
المؤلفون: Kongmalai, Tanawan, Srinonprasert, Varalak, Anothaisintawee, Thunyarat, Kongmalai, Pinkawas, McKay, Gareth, Attia, John, Thakkinstian, Ammarin
المصدر: Kongmalai , T , Srinonprasert , V , Anothaisintawee , T , Kongmalai , P , McKay , G , Attia , J & Thakkinstian , A 2023 , ' New anti-diabetic agents for the treatment of non-alcoholic fatty liver disease: a systematic review and network meta-analysis of randomized controlled trials ' , Frontiers in Endocrinology , vol. 14 , 1182037 . https://doi.org/10.3389/fendo.2023.1182037
مصطلحات موضوعية: Humans, Non-alcoholic Fatty Liver Disease/drug therapy, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Network Meta-Analysis, Glucagon-Like Peptide-1 Receptor, Randomized Controlled Trials as Topic, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide 1/therapeutic use, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being
وصف الملف: application/pdf
-
3Academic Journal
المؤلفون: Neuville, M F, Paquot, Nicolas, Scheen, André
المصدر: Revue Médicale de Liège, 78 (1), 40-45 (2023-01)
مصطلحات موضوعية: Hypoglycemic Agents, 839I73S42A (Liraglutide), Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptides, Glucagon-Like Peptide 1, Humans, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents/pharmacology/therapeutic use, Liraglutide/pharmacology/therapeutic use, Glucagon-Like Peptide-1 Receptor/agonists, Glucagon-Like Peptides/pharmacology/therapeutic use, Glucagon-Like Peptide 1/therapeutic use, Weight Loss, Obesity/drug therapy, GLP, Glucagon, Obesity, Tirzepatide, Type 2 diabetes, GIP, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition
Time: 1
Relation: urn:issn:0370-629X; urn:issn:2566-1566; https://orbi.uliege.be/handle/2268/300361; info:hdl:2268/300361; info:pmid:36634066
-
4Academic Journal
المؤلفون: Neuville, M F, Paquot, Nicolas, Scheen, André
المصدر: Revue Médicale de Liège, 78 (1), 40-45 (2023-01)
مصطلحات موضوعية: Hypoglycemic Agents, 839I73S42A (Liraglutide), Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptides, Glucagon-Like Peptide 1, Humans, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents/pharmacology/therapeutic use, Liraglutide/pharmacology/therapeutic use, Glucagon-Like Peptide-1 Receptor/agonists, Glucagon-Like Peptides/pharmacology/therapeutic use, Glucagon-Like Peptide 1/therapeutic use, Weight Loss, Obesity/drug therapy, GLP, Glucagon, Obesity, Tirzepatide, Type 2 diabetes, 1, GIP, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Pharmacie, pharmacologie & toxicologie
Relation: urn:issn:0370-629X; urn:issn:2566-1566
URL الوصول: https://orbi.uliege.be/handle/2268/300361
-
5Academic Journal
المؤلفون: Al-Mashhadi, Zheer Kejlberg, Viggers, Rikke, Fuglsang-Nielsen, Rasmus, Vestergaard, Peter, Gregersen, Søren, Starup-Linde, Jakob
المصدر: Al-Mashhadi , Z K , Viggers , R , Fuglsang-Nielsen , R , Vestergaard , P , Gregersen , S & Starup-Linde , J 2022 , ' The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors : A Danish nationwide cohort study ' , Frontiers in Endocrinology , vol. 13 , 882998 . https://doi.org/10.3389/fendo.2022.882998
مصطلحات موضوعية: Humans, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Glucagon-Like Peptide-1 Receptor/agonists, Diabetes Mellitus, Type 2/complications, Osteoporotic Fractures/epidemiology, Cohort Studies, Metformin/therapeutic use, Denmark/epidemiology, Glucagon-Like Peptide 1/therapeutic use
-
6Academic Journal
المؤلفون: Ana Paula Martins, Rodrigo Miguel Martins Murteira
المصدر: Revista Portuguesa de Farmacoterapia, Vol 8, Iss 2, Pp 28-38 (2016)
مصطلحات موضوعية: Diabetes Mellitus, Type 2/drug therapy, Exenatide, Glucagon-Like Peptide 1/therapeutic use, Glucagon-Like Peptide 1/analogs & derivatives, Liraglutide, Safety, Treatment Outcome, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
7
المؤلفون: Mark P. Plummer, Jeroen Hermanides, Adam M. Deane
المصدر: Critical Care Clinics. 35:341-355
مصطلحات موضوعية: Blood Glucose, Male, Physiology, Type 2 diabetes, Gastrointestinal Hormone/therapeutic use, Pharmacology, Critical Care and Intensive Care Medicine, 0302 clinical medicine, Glucagon-Like Peptide 1, Glucagon-Like Peptide 1/therapeutic use, Receptors, 80 and over, Medicine, Aged, 80 and over, Incretins/therapeutic use, digestive, oral, and skin physiology, Critical Care/methods, Glucagon secretion, Glycemic Index/drug effects, General Medicine, Middle Aged, Glucagon-like peptide-1, Postprandial, Type 2/drug therapy, Gastric Inhibitory Polypeptide/therapeutic use, Female, hormones, hormone substitutes, and hormone antagonists, Adult, endocrine system, Critical Care, Incretin, Hypoglycemic Agents/therapeutic use, Gastric Inhibitory Polypeptide, Incretins, Receptors, Gastrointestinal Hormone, 03 medical and health sciences, Blood Glucose/drug effects, Diabetes mellitus, Diabetes Mellitus, Humans, Hypoglycemic Agents, Aged, Glycemic, Gastric emptying, business.industry, 030208 emergency & critical care medicine, medicine.disease, Diabetes Mellitus, Type 2, 030228 respiratory system, Glycemic Index, business
-
8Academic Journal
المؤلفون: Puddu, Alessandra, Sanguineti, Roberta, Mach, François, Dallegri, Franco, Viviani, Giorgio Luciano, Montecucco, Fabrizio
المصدر: ISSN: 0962-9351 ; Mediators of inflammation, vol. 2013 (2013) 750540.
مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Calcium/metabolism, Diabetes Mellitus, Type 2/drug therapy/metabolism/physiopathology, Glucagon-Like Peptide 1/therapeutic use, Humans, Hypoglycemic Agents/therapeutic use, Insulin-Secreting Cells/drug effects/metabolism, Metformin/therapeutic use, MicroRNAs/metabolism
Relation: info:eu-repo/semantics/altIdentifier/pmid/23737653; https://archive-ouverte.unige.ch/unige:77513; unige:77513
-
9
المؤلفون: Kristina S. Boye, Mitch DeKoven, Hélène Sapin, Kirsi Norrbacka, Farhad Ali Khan, Victoria Divino
المصدر: Diabetes Therapy
مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Lira, Lixisenatide, 030209 endocrinology & metabolism, Type 2 diabetes, Pharmacology, Persistence, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Diabetes mellitus, Internal medicine, Internal Medicine, medicine, 030212 general & internal medicine, Glucagon-like peptide 1/analogs and derivatives, Survival analysis, Exenatide QW, Original Research, Treatment patterns, Liraglutide, business.industry, Retrospective cohort study, Exenatide BID, medicine.disease, Discontinuation, Retrospective studies, chemistry, Type 2/drug therapy, Glucagon-like peptide 1/therapeutic use, business, Exenatide, medicine.drug
-
10
المصدر: Revista Portuguesa de Farmacoterapia, Vol 8, Iss 2, Pp 28-38 (2016)
Revista Portuguesa de Farmacoterapia / Portuguese Journal of Pharmacotherapy; Vol 8 No 2 (2016): Abril; 28-38
Revista Portuguesa de Farmacoterapia; v. 8 n. 2 (2016): Abril; 28-38
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAPمصطلحات موضوعية: lcsh:Therapeutics. Pharmacology, lcsh:RM1-950, Diabetes Mellitus, Type 2/drug therapy, Exenatide, Glucagon-Like Peptide 1/therapeutic use, Glucagon-Like Peptide 1/analogs & derivatives, Liraglutide, Safety, Treatment Outcome
وصف الملف: application/pdf
-
11
المؤلفون: Roberta Sanguineti, Giorgio Luciano Viviani, Fabrizio Montecucco, François Mach, Franco Dallegri, Alessandra Puddu
المصدر: Mediators of Inflammation; Vol 2013
Mediators of Inflammation
Mediators of Inflammation, Vol. 2013 (2013) P. 750540
Mediators of Inflammation, Vol 2013 (2013)مصطلحات موضوعية: medicine.medical_specialty, Calcium/metabolism, medicine.medical_treatment, Insulin-Secreting Cells/drug effects/metabolism, Immunology, Hypoglycemic Agents/therapeutic use, 030209 endocrinology & metabolism, Review Article, Bioinformatics, Diabetes Mellitus, Type 2/drug therapy/metabolism/physiopathology, 03 medical and health sciences, 0302 clinical medicine, Glucagon-Like Peptide 1, Insulin-Secreting Cells, Diabetes mellitus, Internal medicine, Glucagon-Like Peptide 1/therapeutic use, microRNA, lcsh:Pathology, Extracellular, MicroRNAs/metabolism, Humans, Hypoglycemic Agents, Medicine, Glucose homeostasis, Metformin/therapeutic use, 030304 developmental biology, ddc:616, 0303 health sciences, business.industry, Insulin, Cell Biology, medicine.disease, Glucagon-like peptide-1, Metformin, 3. Good health, MicroRNAs, Endocrinology, Diabetes Mellitus, Type 2, Calcium, business, Function (biology), lcsh:RB1-214, medicine.drug